Robert Bartlett - Aug 20, 2024 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Role
CEO and President, Director
Signature
/s/ Robert Bartlett
Stock symbol
PURE
Transactions as of
Aug 20, 2024
Transactions value $
$0
Form type
4
Date filed
8/22/2024, 05:58 PM
Previous filing
Aug 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PURE Stock Option (Right to Buy) Award $0 +155K $0.00 155K Aug 20, 2024 Common Stock 155K $0.07 Direct F1
transaction PURE Stock Option (Right to Buy) Award $0 +500K $0.00 500K Aug 20, 2024 Common Stock 500K $0.07 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest and become exercisable in four equal installments on November 20, 2024, February 20, 2025, May 20, 2025, and August 20, 2025.
F2 The option shares are fully vested as of the date of grant.